Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy.

Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy.

Item
http://www.wikidata.org/entity/Q48789028
The Prognostic Value of Platelet Count in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-AnalysisCirculating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insightsHighlights for α-fetoprotein in determining prognosis and treatment monitoring for hepatocellular carcinoma.Comparison of long-term survival of patients with solitary large hepatocellular carcinoma of BCLC stage A after liver resection or transarterial chemoembolization: a propensity score analysis.Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization.Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer stagingUse of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration.Prognosis of Early-Stage Hepatocellular Carcinoma: The Clinical Implications of Substages of Barcelona Clinic Liver Cancer System Based on a Cohort of 1265 PatientsCirculating markers for prognosis of hepatocellular carcinoma.Changes of alpha-fetoprotein levels could predict recurrent hepatocellular carcinoma survival after trans-arterial chemoembolization.The 4th Asia-Pacific Primary Liver Cancer Expert MeetingPotential of alpha-fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinoma.Prognostic role of alpha-fetoprotein response after hepatocellular carcinoma resection.Radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of overall survival and recurrence-free survival
P2860

Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy.

Item
http://www.wikidata.org/entity/Q48789028
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Serum alpha-fetoprotein respon ...... diofrequency ablation therapy.
@en
Serum alpha-fetoprotein respon ...... diofrequency ablation therapy.
@nl
type
label
Serum alpha-fetoprotein respon ...... diofrequency ablation therapy.
@en
Serum alpha-fetoprotein respon ...... diofrequency ablation therapy.
@nl
prefLabel
Serum alpha-fetoprotein respon ...... diofrequency ablation therapy.
@en
Serum alpha-fetoprotein respon ...... diofrequency ablation therapy.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Serum alpha-fetoprotein respon ...... adiofrequency ablation therapy
@en
P2093
P304
P31
P356
10.1016/J.CRAD.2011.10.009
P433
P478
P50
P577
P5875
P698